Odds ratio (with 95% confidence interval) of indirect comparisons of edoxaban versus dabigatran, rivaroxaban and apixaban.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_Odds_ratio_with_95_confidence_interval_of_indirect_comparisons_of_edoxaban_versus_dabigatran_rivaroxaban_and_apixaban_/1080709 数据链接链接失效反馈

官方服务：

资源简介：

Safety end-points. Significant comparisons are printed in bold.

创建时间：

2015-12-02

Demographic data of short pulse duration PC group and conventional PC group.

糖尿病视网膜病变

抗凝治疗比较

Data are shown as the mean ± standard deviation. Unpaired t-test or Chi-squared test was used to compare between the groups. eGFR, estimated glomerular filtration rate; PRP, pan-retinal photocoagulati

NIAID Data Ecosystem50

Simulation results of the indirect and mixed A-B treatment comparisons in the different scenarios when the true treatment effect was -0.5, the between-trial heterogeneity for baseline risk was set at 0.01 and the between-trial heterogeneity of the treatment effect was set at 0.01.

网络荟萃分析模拟

间接治疗比较

Simulation results of the indirect and mixed A-B treatment comparisons in the different scenarios when the true treatment effect was -0.5, the between-trial heterogeneity for baseline risk was set at

NIAID Data Ecosystem40

Dataset from A Phase III, Randomised, Double Blind, Parallel-group Study of the Efficacy and Safety of Oral Dabigatran Etexilate (150 mg Bid) Compared to Warfarin (INR 2.0-3.0) for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism, Following Initial Treatment (5-10 Days) With a Parenteral Anticoagulant Approved for This Indication

抗凝治疗比较

静脉医学研究

The general aim of this study is to determine the comparative safety and efficacy of dabigatran etexilate 150 mg bid administered orally and warfarin Pro re nata (As needed/PRN) to maintain an Interna

NIAID Data Ecosystem20

IPT-weighted cumulative incidence and SHRs in the intention-to-treat analysis for factor Xa inhibitor cohort versus the dabigatran cohort during 5 years of follow-up.

抗凝治疗比较

临床结局研究

IPT-weighted cumulative incidence and SHRs in the intention-to-treat analysis for factor Xa inhibitor cohort versus the dabigatran cohort during 5 years of follow-up.

NIAID Data Ecosystem40

Effect of ticagrelor monotherapy versus clopidogrel plus aspirin in aging patients with unstable angina pectoris after elective percutaneous coronary intervention

心血管药物

抗凝治疗比较

The study aim to compare ticagrelor monotherapy following ticagrelor dual antiplatelet therapy (DAPT) (ticagrelor + aspirin) with clopidogrel DAPT (clopidogrel + aspirin) in elderly patients with unst

NIAID Data Ecosystem20

Odds ratio (with 95% confidence interval) of indirect comparisons of edoxaban versus dabigatran, rivaroxaban and apixaban.

资源简介：

相关数据集